MedPath

INSTITUT CURIE

INSTITUT CURIE logo
🇫🇷France
Ownership
Private
Established
1909-01-01
Employees
1K
Market Cap
-
Website
http://www.curie.fr

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis

Phase 2
Not yet recruiting
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
Drug: 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy
First Posted Date
2024-10-26
Last Posted Date
2024-10-30
Lead Sponsor
Institut Curie
Target Recruit Count
35
Registration Number
NCT06659705
Locations
🇫🇷

Institut Curie -site Saint-Cloud, Saint-cloud, France

Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds

Not Applicable
Recruiting
Conditions
Malignant Wound
Interventions
Other: Algosteril
First Posted Date
2024-09-03
Last Posted Date
2025-03-28
Lead Sponsor
Institut Curie
Target Recruit Count
108
Registration Number
NCT06581809
Locations
🇫🇷

EHPAD Laurent Antoine, Agde, France

🇫🇷

Hôpital Saint-Loup, Agde, France

🇫🇷

Centre François Baclesse, Caen, France

and more 9 locations

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid

Not Applicable
Recruiting
Conditions
Metastatic Breast Cancer
Interventions
Procedure: Biopsy
First Posted Date
2024-06-14
Last Posted Date
2025-03-18
Lead Sponsor
Institut Curie
Target Recruit Count
110
Registration Number
NCT06459791
Locations
🇫🇷

Institut Curie, Saint-Cloud, France

🇫🇷

Hôpital Saint-Louis - AP-HP Senopole, Paris, France

Optimizing Bronchopulmonary Cancer Screening

Not Applicable
Recruiting
Conditions
Diagnoses Disease
Bronchopulmonary Disease
Interventions
Other: Screening
Other: Inclusion
Other: Chest CTscan and follow-up
First Posted Date
2024-06-03
Last Posted Date
2025-02-03
Lead Sponsor
Institut Curie
Target Recruit Count
500
Registration Number
NCT06439901
Locations
🇫🇷

Centre CTPS Bobigny Bondy, Bobigny, France

🇫🇷

Centre Municipal de Santé Simone Veil, Issy-les-Moulineaux, France

🇫🇷

Centre Municipal de Santé Jacqueline Akoun-Cornet, Malakoff, France

and more 5 locations

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

Not Applicable
Recruiting
Conditions
Triple Negative Breast Cancer
Interventions
Procedure: 68Ga-FAPI-46 PET/CT imaging
First Posted Date
2024-04-05
Last Posted Date
2024-10-18
Lead Sponsor
Institut Curie
Target Recruit Count
60
Registration Number
NCT06349512
Locations
🇫🇷

Hôpital Privé d'Antony, Antony, France

🇫🇷

Institut Curie -site Paris, Paris, France

🇫🇷

GH Diaconesses Croix Saint-Simon, Paris, France

and more 3 locations

A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
Drug: PLX038 + Tuvusertib
First Posted Date
2024-03-29
Last Posted Date
2025-03-03
Lead Sponsor
Institut Curie
Target Recruit Count
92
Registration Number
NCT06337630
Locations
🇫🇷

Institut Curie, Saint-Cloud, France

Early Detection of Triple Negative Breast Cancer Relapse

Not Applicable
Not yet recruiting
Conditions
Triple Negative Breast Cancer
Interventions
Diagnostic Test: ctDNA monitoring
Diagnostic Test: 68Ga-FAPI-46-PET-CT
First Posted Date
2024-01-26
Last Posted Date
2024-06-20
Lead Sponsor
Institut Curie
Target Recruit Count
450
Registration Number
NCT06225505
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

🇫🇷

CHU Nîmes, Nîmes, France

🇫🇷

Hôpital Tenon, Paris, France

and more 10 locations

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Phase 3
Recruiting
Conditions
Breast Carcinoma
Interventions
Combination Product: Endocrine therapy
Combination Product: Endocrine therapy combined with the local treatment of FES-negative lesions
Combination Product: Chemotherapy
First Posted Date
2024-01-08
Last Posted Date
2024-06-20
Lead Sponsor
Institut Curie
Target Recruit Count
300
Registration Number
NCT06195709
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

🇫🇷

Centre Francois Baclesse, Caen, France

🇫🇷

Centre Georges Francois Leclerc, Dijon, France

and more 9 locations

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

Phase 2
Recruiting
Conditions
Triple Negative Breast Cancer
Interventions
Radiation: 68Ga-FAPI-46 PET/CT
Biological: Tumor samples analysis
First Posted Date
2023-12-18
Last Posted Date
2024-04-08
Lead Sponsor
Institut Curie
Target Recruit Count
160
Registration Number
NCT06175390
Locations
🇫🇷

Institut Curie, Saint-Cloud, France

A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer

Phase 2
Recruiting
Conditions
Breast
Cancer
Interventions
First Posted Date
2023-12-08
Last Posted Date
2024-10-07
Lead Sponsor
Institut Curie
Target Recruit Count
44
Registration Number
NCT06162351
Locations
🇫🇷

Institut Curie, Saint Cloud, France

© Copyright 2025. All Rights Reserved by MedPath